Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

PURPOSE: It remains unclear whether eosinophilia is useful for in guiding inhaled corticosteroid (ICS) therapy in chronic obstructive pulmonary disease (COPD) patients. The goal of this study is to evaluate the risk of acute exacerbations, COPD‐related hospitalisations/accident and emergency visits,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmacoepidemiol Drug Saf
Autori principali: Oshagbemi, Olorunfemi A., Franssen, Frits M.E., Braeken, Dionne C.W., Henskens, Yvonne, Wouters, Emiel F.M., Maitland‐van der Zee, Anke‐Hilse, Burden, Andrea M., de Vries, Frank
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282838/
https://ncbi.nlm.nih.gov/pubmed/30264901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4655
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi